Clinical Trials Logo

Clinical Trial Summary

The infant gut microbiota, a major driver of the maturation of the immune system, is formed through the successive establishment and development during infancy and early childhood. It can inhibit the growth of pathogenic bacteria, prevent the occurrence of diseases and improve the child's quality of life. It is therefore important to regulate the microbiota balance in infants and young children. This objective of this post-launch study is to evaluate the effects of a formula with prebiotics and milk fat on the gut microbiota and stool characteristics of healthy Chinese infants and young children. The duration of the study for each participant is 32 days and includes 3 study visits.

Clinical Trial Description


Study Design

NCT number NCT04864665
Study type Interventional
Source Danone Nutricia
Contact Mengjin LIU
Phone +86-21-61798888
Email [email protected]
Status Not yet recruiting
Phase N/A
Start date May 10, 2021
Completion date May 11, 2022